Fibrin Matrix Therapy Products in Indianapolis, IN

What I’d check before adding fibrin matrix therapy here

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 13% of adults in Indianapolis have diagnosed diabetes — 1.0 points above the U.S. 12% figure. 11.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick fibrin matrix therapy against that mix.

Where Indianapolis programs actually stall

• CDC PLACES (2023, crude) estimates 13% of adults in Indianapolis have diagnosed diabetes — 1.0 points above the U.S. 12% figure. Adult obesity in Indianapolis is 38.2% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails J8 review. Product is the last step, not the first.
• Collagen dressings and CTPs are not interchangeable on a claim. WPS Government Health Administrators packaging, units, and wastage rules differ. Buying the wrong format for the wound stage is an expensive inventory error.
• First Coast (Florida) is the only single-state MAC; every other state shares a contractor with neighbors. Indiana is J8 — copy-pasting a Florida LCD packet here is a denial pattern we still see.

Uninsured mix and Medicare CTPs in the same building

J8 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Indianapolis is 13% or not. PLACES is planning data. The LCD is the claim.

Before the first fibrin matrix therapy shipment